Pipetting precision advances lithium therapy toxicity research

Integrating cutting-edge technology, Integra Biosciences generously provided three PIPETBOY acu 2 serological pipette controllers to the 2023 iGEM Competition team at Technische Universität Braunschweig (TU_BS). These advanced controllers played a pivotal role in enhancing the precision of pipetting tasks, facilitating the team's pioneering research in lithium therapy toxicity testing.

The project, known as Li+onSwitch, explored the development of a self-testing method for monitoring blood lithium levels at home. Daniel, a member of the 2023 iGEM team, explained: “A large part of our work included designing our own plasmid constructs and testing potential reporter systems, and we worked extensively with liquid cultures. We were very excited to receive the PIPETBOY controllers, and they quickly became essential daily tools in our lab, significantly speeding up our repetitive pipetting protocols. This huge cumulative time saving led to greater productivity, and freed us up to focus on other aspects of our research. The PIPETBOYs are also extremely precise instruments, so helped to improve the reproducibility and consistency of our many manual liquid handling tasks.”

The team's outstanding achievements, including winning Best Diagnostics Project and receiving a gold medal, highlight the success of their diligent efforts and innovative approach.

Learn more about the Li+onSwitch project and Integra's commitment to supporting the next generation of synthetic biologists.

More information online: